Loading...

Table of Content

    08 May 2022, Volume 26 Issue 13 Previous Issue    Next Issue
    For Selected: Toggle Thumbnails
    SV40 large T gene induces immortalization of human bone marrow mesenchymal stem cells
    Zhang Luwen, Dai Pengxiu, Zhang Yihua, Chen Yijing, Wang Jinglu, Li Jiakai
    2022, 26 (13):  1969-1973.  doi: 10.12307/2022.319
    Abstract ( 500 )   PDF (1645KB) ( 46 )   Save
    BACKGROUND: Cell immortalization is a characteristic of cells acquiring the ability to continue to proliferate. The large T antigen gene can improve the efficiency of cell immortalization, and is widely used in experiments, attracting more and more attention from researchers. 
    OBJECTIVE: To establish an immortalized cell line of human bone marrow mesenchymal stem cells and lay the foundation for the clinical application of human bone marrow mesenchymal stem cells.
    METHODS: The recombinant plasmid vector containing the SV40 large T antigen gene was used to transfect human bone marrow mesenchymal stem cells, which were successively subcultured and identified by methods, such as morphology, cell proliferation ability, cell surface markers, and multidirectional differentiation potential.
    RESULTS AND CONCLUSION: (1) The immortalized cell line constructed by this method is an adherent growth of spindle cells with specific surface markers of human bone marrow mesenchymal stem cells. (2) The 50th generation of human bone marrow mesenchymal stem cells can still express SV40 large T antigen gene after transfection. (3) The proliferation ability of the immortalized cell line is better than that of untransfected human bone marrow mesenchymal stem cells. (4) The immortalized cell line has the potential to differentiate into osteogenic, adipogenic, and chondrogenic cells. (5) This shows that transfection of the SV40 large T antigen gene does not affect the biological characteristics and differentiation ability of human bone marrow mesenchymal stem cells. This method can be used to establish immortalized human bone marrow mesenchymal stem cells.
    Figures and Tables | References | Related Articles | Metrics
    Histological comparison between goat bone marrow mesenchymal stem cells and adhesive fibrin for the repair of annulus fibrosus defect of intervertebral discs
    Xu Xiang, Wu Yimin, Li Shuwen, Ma Libo, Wang Yupeng, Yu Yingnan, Sun Tao, Zhang Yuan, Ren Wei, Yin Heping
    2022, 26 (13):  1974-1978.  doi: 10.12307/2022.320
    Abstract ( 419 )   PDF (2912KB) ( 29 )   Save
    BACKGROUND: At present, after lumbar discectomy, annulus fibrosus rupture still exists, easy to form recurrent lumbar disc herniation. How to repair the broken annulus fibrosus is a hot issue in tissue engineering.  
    OBJECTIVE: To compare the ability of goat bone marrow mesenchymal stem cell transplantation with gelatin sponge as carrier and adhesive fibrin repair for annulus fibrosus defects.
    METHODS:  Bone marrow mesenchymal stem cells were extracted and isolated from the goat iliac bone and transferred for culture. Fifteen goats were randomized into control, adhesion, and transplant groups (n=5 per group and 30 discs per group). The 0.75 cm×0.75 cm disc annulus fibrosus defect was made with surgical instruments. In the binding group, the damage was bonded with fibrin adhesive. In the transplant group, the gelatin sponge (0.75 cm×0.75 cm) with bone marrow mesenchymal stem cell suspension (cell concentration: 5×109/L, 10 μL) was placed into the annulus fibrosus defect and the lesion was stitched layer by layer. At 6 and 12 weeks after surgery, annulus fibrosus tissue was removed for hematoxylin-eosin staining, Masson staining, AB-PAS staining, and type II collagen staining.  
    RESULTS AND CONCLUSION: Hematoxylin-eosin staining results showed that the number of chondrocytes, collagen cells and bone cells in the transplant group increased, the cells were mature and the repair ability was stronger compared with the other two groups. Masson staining demonstrated that the number of fibroblasts and fibrous tissue was more in the transplant group compared with the other two groups. AB-PAS staining exhibited that more chondrocytes in the transplant group were involved in repair compared with the other two groups. Type II collagen staining showed that the content of type II collagen was highest in the transplant group. The above results confirm that goat bone marrow mesenchymal stem cells have a perfect ability to repair annulus fibrosus defects.
    Figures and Tables | References | Related Articles | Metrics
    Wnt/beta-catenin signaling pathway in the treatment of chronic obstructive pulmonary disease with bone marrow mesenchymal stem cells
    Zhong Yulan, Zhou Xiangxiang, Gan Xin
    2022, 26 (13):  1979-1984.  doi: 10.12307/2022.321
    Abstract ( 421 )   PDF (2171KB) ( 49 )   Save
    BACKGROUND: Bone marrow mesenchymal stem cells (BMSCs) have a wide application prospect for the treatment of respiratory diseases. In recent years, studies have shown that the Wnt/β-catenin signaling pathway plays an important role in regulating the directional differentiation of BMSCs and promoting paracrine function.
    OBJECTIVE: To investigate the effect of Wnt/β-catenin signaling pathway activation on chronic obstructive pulmonary disease after transplantation with BMSCs.
    METHODS: Whole bone marrow adherence method was used to extract rat BMSCs. Rat BMSCs were infected with Wnt3a lentivirus. The chronic obstructive pulmonary disease rat model was constructed by intratracheal infusion of lipopolysaccharide combined with smoking method. After model establishment, BMSCs, GFP-BMSCs, and Wnt3a-BMSCs were implanted through the tail vein. PBS was injected through the tail vein in the model and normal control groups. The rats in each group were sacrificed at 7, 14, and 28 days. The pathological changes of rat lung tissue were observed by hematoxylin-eosin staining. The levels of interleukin-10 and tumor necrosis factor alpha in arterial blood were detected by ELISA.  
    RESULTS AND CONCLUSION: (1) The pathological results of hematoxylin-eosin staining showed that the pathological changes of the three BMSCs transplantation groups were significantly improved compared with the model group, and the Wnt3a-BMSCs group improved significantly. (2) At the same time point, the arterial blood tumor necrosis factor alpha level was lower in the three BMSCs transplantation groups than that in the model group (all P < 0.05), and there was little difference between the BMSCs group and the GFP-BMSCs group. However, the level in the Wnt3a-BMSCs group was relatively lower than that in the other two groups (P < 0.05). Arterial blood interleukin-10 level was higher in the three BMSCs transplantation groups than that in the model group (all P < 0.05), among which there was little difference between the BMSCs group and the GFP-BMSCs group. However, the level in the Wnt3a-BMSCs group was significantly higher than that in the other two groups (P < 0.05). (3) The results show that transplantation of BMSCs overexpressing Wnt3a (after Wnt/β-catenin signaling pathway activation) into chronic obstructive pulmonary disease rats can significantly improve the pathological changes of lung tissue, increase the expression of anti-inflammatory factor interleukin-10 and reduce the expression of tumor necrosis factor alpha, and enhance the anti-inflammatory effect of BMSCs. 
    Figures and Tables | References | Related Articles | Metrics
    Protective effect of lipopolysaccharide-preconditioned astrocyte extracellular vesicles on neurons
    Sun Haitao, Huang Yonghui, Gong Aihua, Cao Xingbing, Li Zhen
    2022, 26 (13):  1985-1992.  doi: 10.12307/2022.322
    Abstract ( 416 )   PDF (3175KB) ( 102 )   Save
    BACKGROUND: Central nervous system diseases are often closely related to neuronal apoptosis. Astrocytes are closely related to neurons. It remains poorly understood whether extracellular vesicles, which are derived from astrocytes, especially activated astrocytes, may inhibit glutamate-induced neuronal apoptosis, thereby exerting neuroprotective effect. 
    OBJECTIVE: To investigate the role and possible mechanism of astrocyte extracellular vesicles (AS-EVs) and lipopolysaccharide-preconditioned astrocyte extracellular vesicles (LPAS-EVs) in glutamate-induced neuronal injury. 
    METHODS: Astrocyte was cultured in vitro and induced activation model was established by lipopolysaccharide. The supernatant of cells of two groups was collected and extracellular vesicles were extracted by hypervelocity centrifuges, and then identified. PC12 cells were used for preliminary experiments. First, we investigated the effects of AS-EVs and LPAS-EVs on PC12 cell proliferation, and then established the PC12 cells and primary neurons injury model induced by glutamate. Experiment was divided into four groups: PBS group (PBS of the same volume as EVs groups, 24 hours), glutamate group (10 mmol/L glutamate, 24 hours), AS-EVs group (200 mg/L AS-EVs, 24 hours + 10 mmol/L glutamate, 24 hours), and LPAS-EVs group (200 mg/L LPAS-EVs, 24 hours + 10 mmol/L glutamate, 24 hours). The survival rate of PC12 cells was determined by CCK-8 assay. Western blot assay was used to detect the expression of apoptosis related proteins Bax and Bcl-2.   
    RESULTS AND CONCLUSION: (1) Astrocyte was extracted and lipopolysaccharide-induced astrocyte activation model was established successfully. (2) AS-EVs and LPAS-EVs were successfully extracted, which met the morphological standards of extracellular vesicles and showed positive expression of related markers. (3) AS-EVs and LPAS-EVs had no significant effect on PC12 cells proliferation. (4) Compared with glutamate group, AS-EVs and LPAS-EVs could improve the survival rate of PC12 cells, and the effect of LPAS-EVs was stronger than that of AS-EVs (all P < 0.05, n=3). (5) AS-EVs and LPAS-EVs could inhibit the pro-apoptotic protein Bax expression and promote the expression of anti-apoptotic protein Bcl-2 (all P < 0.01, n=3), and then inhibited apoptosis of PC12 cells and primary neurons, thus playing a neuroprotective role, and the effect of LPAS-EVs was stronger than that of AS-EVs (all P < 0.05). (6) The results conclude that extracellular vesicles derived from astrocytes can inhibit the apoptosis of neurons injured by glutamate, which has a neuroprotective effect, and this effect is enhanced after being stimulated by lipopolysaccharide. 
    Figures and Tables | References | Related Articles | Metrics
    Mechanism of separation of graft-versus-host disease and graft versus leukemia in unrelated cord blood transplantation for hematological malignancies
    Xu Anhui, Lin Xiuxiu, Zhang Xuhan, Song Kaidi, Sun Guangyu, Tang Baolin, Sun Zimin, Zheng Changcheng
    2022, 26 (13):  1993-1999.  doi: 10.12307/2022.323
    Abstract ( 386 )   PDF (1629KB) ( 35 )   Save
    BACKGROUND: Numerous clinical studies in and outside China have shown that unrelated cord blood transplantation has a lower incidence of graft-versus-host disease compared with peripheral blood stem cell or bone marrow transplantation, and the recurrence rate of the disease is also markedly reduced. It has a strong graft versus leukemia effect and is one of the models for clinically separating graft-versus-host disease and graft versus leukemia effect. How the immune cells differentiate after unrelated cord blood transplantation and why the transplant has a strong graft versus leukemia effect; the mechanism is still unclear. 
    OBJECTIVE: To retrospectively analyze the long-term clinical follow-up data of unrelated cord blood transplantation patients, investigate dominant cell subsets and differentiation, related activation and expression of inhibitory molecules after unrelated cord blood transplantation, and further explore the mechanism of graft-versus-host disease and graft versus leukemia separation of unrelated cord blood transplantation.  
    METHODS: From July 1, 2012 to June 31, 2017, 154 adult patients with hematologic malignancies received hematopoietic stem cell transplantation, including 93 cases of unrelated cord blood transplantation and 61 cases of sibling peripheral blood stem cell transplantation. The immune characteristics of T cells in patients with unrelated cord blood transplantation were studied by collecting bone marrow samples from patients with unrelated cord blood transplantation and peripheral blood stem cell transplantation, and the separation of clinical graft-versus-host disease and graft versus leukemia effect in unrelated cord blood transplantation was investigated.  
    RESULTS AND CONCLUSION: (1) After a median follow-up of 61 months (42-99 months), the 5-year prevalence of chronic graft-versus-host disease and five year-relapse in unrelated cord blood transplantation group were significantly lower than those in peripheral blood stem cell transplantation group (P=0.003). Integration of III-IV graft-versus-host disease, extensive chronic graft-versus-host disease and disease recurrence, 5-year graft-versus-host disease-free and disease-free survival were significantly higher in the unrelated cord blood transplantation group than those in the peripheral blood stem cell transplantation group (P=0.038). (2) The percentage of CD3+ T cells was significantly higher in unrelated cord blood transplantation group than that in the peripheral blood stem cell transplantation group (P=0.04). The percentage of CD3+CD4+ T cell subsets in unrelated cord blood transplantation group was lower than that in the peripheral blood stem cell transplantation group. The percentage of CD3+CD8+ cell subsets in unrelated cord blood transplantation group was higher than that in the peripheral blood stem cell transplantation group. The percentage of CD4+CD80+ T cells in unrelated cord blood transplantation group was lower than that in the peripheral blood stem cell transplantation group (P=0.089). The percentage of CD4+PD-1+ T cells in the unrelated cord blood transplantation group was higher than that in the peripheral blood stem cell transplantation group. The percentage of CD8+CD80+ T cells in the unrelated cord blood transplantation group was higher than that in the peripheral blood stem cell transplantation group. (3) The results suggest that unrelated cord blood transplantation patients not only have lower chronic graft-versus-host disease, but also have lower disease recurrence rate, showing the separation of graft-versus-host disease and graft versus leukemia. Immune function test showed that the proportion of T cells in unrelated cord blood transplantation group was relatively high, and CD8+ T cells were the dominant subset, which may be one of the mechanisms of strong graft versus leukemia effect of unrelated cord blood transplantation.  
    Figures and Tables | References | Related Articles | Metrics
    Mechanism of paeoniflorin on bone marrow mesenchymal stem cells intervened by lipopolysaccharide
    Li Min, Yu Yang, Cheng Jiyan
    2022, 26 (13):  2000-2005.  doi: 10.12307/2022.324
    Abstract ( 398 )   PDF (1457KB) ( 52 )   Save
    BACKGROUND: Bone marrow mesenchymal stem cells have strong potential application prospects in tissue engineering, cell therapy and gene therapy. More and more researches have focus on the effective improvement of survival rate and biological effect of bone marrow mesenchymal stem cell transplantation.
    OBJECTIVE: To investigate the effects of paeoniflorin on bone marrow mesenchymal stem cell proliferation, migration and the transforming growth factor-β1, ERK1/2 genes and proteins expression in bone marrow mesenchymal stem cells intervened by lipopolysaccharide.
    METHODS: The effect of paeoniflorin at different concentrations on the proliferation of bone marrow mesenchymal stem cells was detected by cell counting kit-8 assay. Scratch test was used to detect the effect of 10 μmol/L paeoniflorin on the migration ability of bone marrow mesenchymal stem cells. Real-time fluorescence quantitative PCR was used to detect the expression of collagen I, collagen III and Ki67 mRNA under the intervention of 10 μmol/L paeoniflorin. Bone marrow mesenchymal stem cells were divided into control group, lipopolysaccharide group (1 mg/L) and lipopolysaccharide (1 mg/L) + paeoniflorin (80 μmol/L) group. After 72 hours of intervention, real-time fluorescence quantitative PCR and western blot assay were used to detect the transforming growth factor-β1 and ERK1/2 (MAPK3/1) expression of genes and proteins in cells. Transforming growth factor-β1 protein location and semi-quantitative analysis in bone marrow mesenchymal stem cells were detected by immunofluorescence. 
    RESULTS AND CONCLUSION: (1) Paeoniflorin increased the proliferation rate of bone marrow mesenchymal stem cells within a certain concentration (6.25-12.5 μmol/L). (2) The blank scratch area of the 10 μmol/L paeoniflorin group was significantly narrowed compared with the control group (P < 0.05). (3) Compared with the control group, the expression levels of collagen I, collagen III and Ki67 mRNA were significantly increased in the 10 μmol/L paeoniflorin group (P < 0.01). (4) Lipopolysaccharide significantly promoted transforming growth factor-β1, MAPK1, MAPK3 genes and transforming growth factor-β1, p-ERK1/2 protein expression (P < 0.01). After the addition of paeoniflorin, the up-regulated amount was significantly reduced (P < 0.01). (5) Based on the above experimental results, this study concludes that paeoniflorin can promote the proliferation, migration and the expression of collagen I, collagen III and Ki67 genes in bone marrow mesenchymal stem cells. Meanwhile, paeoniflorin can decline the expression of transforming growth factor-β1, ERK1/2 (MAPK3/1) genes and proteins in bone marrow mesenchymal stem cells intervened by lipopolysaccharide. 
    Figures and Tables | References | Related Articles | Metrics
    Low-intensity pulsed ultrasound promotes the proliferation of bone marrow mesenchymal stem cells by inducing cyclin D1 up-regulation
    Li Zhi, Hua Yongyong, Zhang Jianquan, Fu Zhen
    2022, 26 (13):  2006-2011.  doi: 10.12307/2022.325
    Abstract ( 596 )   PDF (1385KB) ( 29 )   Save
    BACKGROUND: Previous studies found that low-intensity pulsed ultrasound can promote the proliferation of human bone marrow mesenchymal stem cells.
    OBJECTIVE: To investigate the mechanism of low-intensity pulsed ultrasound on the proliferation of human bone marrow mesenchymal stem cells via the FAK/PI3K/Akt signaling pathway. 
    METHODS: The purchased commercial human bone marrow mesenchymal stem cells were resuscitated and cultured to the fourth generation, and they were divided into 0 mW/cm2 ultrasound group (control group), 50 mW/cm2 ultrasound group, and 50 mW/cm2 ultrasound + PF-562271 group. The 50 mW/cm2 ultrasound + PF-562271 group was pretreated with 1 μL FAK/PI3K/Akt signaling pathway inhibitor PF-562271 before ultrasound treatment, once every 24 hours, 5 minutes each time. After three stimuli, cell proliferation was detected by Cell Counting Kit-8 and the cell cycle was detected by flow cytometry. Western blot assay was used to detect the expression of FAK and its downstream target gene and cyclin D1. 
    RESULTS AND CONCLUSION: (1) Compared with the control group, the cell proliferation ability was significantly enhanced in the 50 mW/cm2 ultrasound group (P < 0.05). After inhibiting the FAK/PI3K/Akt signaling pathway using PF-562271, the cell proliferation ability was significantly reduced (P < 0.001). (2) Compared with the control group, the expression levels of FAK, p-FAK, PI3K, p-PI3K, Akt, p-Akt and cyclin D1 were all up-regulated in the 50 mW/cm2 ultrasound group (P < 0.05). Compared with the 50 mW/cm2 ultrasound group, the above indicators were significantly reduced in the 50 mW/cm2 ultrasound + PF-562271 group (P < 0.05). (3) Compared with the control group, the proportion of cells in the G1 phase decreased in the 50 mW/cm2 ultrasound group (P=0.026), and the proportion of cells in the S phase increased (P=0.002). Compared with the 50 mW/cm2 ultrasound group, the proportion of cells in G1 phase increased (P=0.023), and the proportion of cells in S phase decreased in the 50 mW/cm2 ultrasound + PF-562271 group (P=0.035). (4) These results indicate that low-intensity pulsed ultrasound promotes the proliferation of human bone marrow mesenchymal stem cells via FAK/PI3K/Akt signaling pathway-induced cyclin D1 up-regulation.
    Figures and Tables | References | Related Articles | Metrics
    Effects of human umbilical cord blood mesenchymal stem cells secreting tumor necrosis factor alpha stimulating gene-6 protein on conversion of mouse bone marrow-derived macrophage subtypes
    Zhao Jiling, Peng Yi, Peng Zhiyong, Yu Guolong
    2022, 26 (13):  2012-2019.  doi: 10.12307/2022.326
    Abstract ( 320 )   PDF (1972KB) ( 29 )   Save
    BACKGROUND: One of the main mechanisms for stem cell transplantation to treat diseases is regulating inflammatory response in a manner of paracrine or distant secretion. Transplanted stem cells secrete a large number of biologically molecules, such as transforming growth factor beta, prostaglandin E2, interleukin 10, and tumor necrosis factor α stimulating gene-6 protein (TSG-6), which affect the conversion of monocyte/macrophages from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype, and coordinating the balance of pro-inflammatory and anti-inflammatory factors. The mechanism by which stem cell secreting factors promote the conversion of monocyte/macrophages M1/M2 subtypes is not clear.  
    OBJECTIVE: To investigate the effects of biologically active molecule secreted by human umbilical cord blood mesenchymal stem cells TSG-6 on the conversions of phenotype and inflammatory factors of mice bone marrow-derived macrophages, and research into the mechanism of TSG-6 protein-mediated M2 polarization in macrophages.
    METHODS:  (1) Bone marrow derived monocytes aseptically extracted from 6-8-week-old Balb/c mice were differentiated into M1 macrophages with lipopolysaccharide and interferon-γ. M1 macrophages were divided into four groups: M1(M1), MT(M1+rhTSG-6), MM(M1+MSCs), and MMsi(M1+MSCs+TSG-6 siRNA). After co-culture for 3 days, cells and supernatant fluid were collected. The macrophages M1/M2 ratio were measured by flow cytometry. The concentrations of inflammatory factors interleukin 1β, interleukin 12, tumor necrosis factor α, transforming growth factor β1, interleukin 10, and TSG-6 were measured by ELISA. Inside the macrophage, p/t-STAT1/3/6 and TSG-6 levels were measured by western blot assay. mRNA expression levels of arginase 1, interleukin 10, inducible nitric oxide synthase, and tumor necrosis factor alpha were measured by RT-PCR. (2) After blocking CD44, M1 macrophages were divided into five groups: M1(M1), MT(M1+rhTSG-6), bMT(M1+TSG-6+blkCD44), MM(M1+MSCs), and bMM(M1+MSC+blkCD44). After co-culture for 3 days, cells were collected to perform western blot assay for the concentrations of CD44 and p/t-STAT1/3/6. RT-PCR was conducted for the expression of CD44 and STAT1/3/6 mRNA and target genes. TSG-6 adhered M1 macrophages were measured by flow cytometry.  
    RESULTS AND CONCLUSION: Mouse M1 macrophages co-cultured with rhTSG-6 or human cord blood mesenchymal stem cells showed: (1) M1 cells decreased, M2 cells increased, and the ratio of M1/M2 decreased (P < 0.05). (2) The pro-inflammatory factors tumor necrosis factor alpha, interleukin 1beta and interleukin 12 decreased (P < 0.05), and the levels of anti-inflammatory factors interleukin 10, transforming growth factor beta1 and TSG-6 increased (P < 0.05). (3) p/t-STAT1 levels decreased and p/t-STAT3/6 level increased (P < 0.05). (4) Tumor necrosis factor alpha and inducible nitric oxide synthase mRNA expression decreased, and interleukin 10 mRNA and arginase 1 mRNA expression increased (P < 0.05). After blocking CD44: (1) TSG-6 adhered macrophages decreased (P < 0.05). (2) CD44 protein and mRNA expression decreased (P < 0.05). (3) The mRNA expression of p/t-STAT1, tumor necrosis factor alpha, and inducible nitric oxide synthase significantly increased (P < 0.05), and the mRNA expression of p/t-STAT3/6, interleukin 10, and arginase 1 (P < 0.01). Therefore, human umbilical cord blood mesenchymal stem cells secreting TSG-6 mediates M1 to M2 conversion and inflammatory regulation in macrophages by affecting STAT 1/3/6 signaling pathway in a CD44-dependent manner.
    Figures and Tables | References | Related Articles | Metrics
    Guilu Erxian Gum medicated serum mediated osteogenic differentiation of rat bone marrow mesenchymal stem cells
    Chen Jincheng, Zhu Guotao, Qin Xiaofei, Chen Yancheng, Luo Jun, Liu Hongwen, Wu Yijing, Xu Jie
    2022, 26 (13):  2020-2026.  doi: 10.12307/2022.327
    Abstract ( 502 )   PDF (2166KB) ( 78 )   Save
    BACKGROUND: On the basis of studying the proliferation of bone marrow mesenchymal stem cells, revealing their differentiation mechanism is one of the hot topics in the study of prevention and treatment of osteoporosis.  
    OBJECTIVE: To explore the relationship between the molecular mechanism of Guilu Erxian Gum medicated serum that induces osteogenic differentiation of bone marrow mesenchymal stem cells to prevent osteoporosis and the activation of extracellular signal-regulated kinase 1/2/E26 transcription factor 1 signaling pathway factors.
    METHODS:  Passage 3 commercial SD rat bone marrow mesenchymal stem cells were purchased, and divided into fetal bovine serum group, blank serum group, Guilu Erxian Gum medicated serum group, classical induction group, pathway inhibitor group, and Guilu Erxian Gum+pathway inhibitor group. Osteogenic differentiation was conducted according to group conditions, and the fluid was altered every 3 days. At 7 days after intervention, alkaline phosphatase activity detection kit was used to determine the osteogenic differentiation level of bone marrow mesenchymal stem cells in the first four groups. At 14 days after intervention, alizarin red staining was used to verify the level of bone formation and mineralization of bone marrow mesenchymal stem cells in the first four groups. Real-time fluorescent quantitative PCR was used to detect the gene expression levels of alkaline phosphatase, core binding protein 2, peroxisome proliferator activated receptor γ, and E26 transcription factor 1 in bone marrow mesenchymal stem cells of the first four groups. Western blot assay was utilized to determine protein expression of type I collagen, alkaline phosphatase, core binding protein 2, peroxisome proliferator activated receptor γ, E26 transcription factor 1, extracellular signal-regulated kinase 1/2 and phosphorylated extracellular signal-regulated kinase 1/2 in bone marrow mesenchymal stem cells of the six groups.  
    RESULTS AND CONCLUSION: (1) Compared with the blank serum group, the mRNA expression levels of alkaline phosphatase, core binding protein 2, and E26 transcription factor 1 were significantly higher in the Guilu Erxian Gum medicated serum group, while the mRNA expression levels of the adipogenic differentiation specific index peroxisome proliferator activated receptor γ were inhibited. (2) Compared with the fetal calf serum group and the blank serum group, the expression levels of osteogenic differentiation-related proteins, such as type I collagen, alkaline phosphatase, core binding protein 2, E26 transcription factor 1, and phosphorylated extracellular signal-regulated kinase 1/2 were significantly increased; and the expression level of peroxisome proliferator activated receptor γ protein was also suppressed. The use of MAPK signaling pathway inhibitor PD98059 could down-regulate the expression levels of osteogenic differentiation-related proteins and up-regulate the expression levels of peroxisome proliferator activated receptor γ protein. (3) Compared with the fetal bovine serum group and the blank serum group, the alkaline phosphatase activity (P < 0.05) and calcification capacity (P < 0.05) of bone marrow mesenchymal stem cells were significantly improved in the Guilu Erxian Gum medicated serum group. (4) The results show that Guilu Erxian Gum medicated serum may mediate the osteogenic differentiation of bone marrow mesenchymal stem cells through extracellular signal-regulated kinase 1/2/E26 transcription factor 1 signaling pathway factors, which may be one of its important mechanisms for preventing and treating osteoporosis.
    Figures and Tables | References | Related Articles | Metrics
    Tissue-engineered bone constructed by co-culture of vascular endothelial cells, adipose derived stem cells, and partially deproteinized biological bone to repair jaw defects
    Liao Xinyu, Wang Fuke, Li Yanlin, Wang Guoliang, Yang Guiran, Hou Jianfei, Yang Tengyun, Zhong Ruiying
    2022, 26 (13):  2027-2033.  doi: 10.12307/2022.328
    Abstract ( 495 )   PDF (1583KB) ( 34 )   Save
    BACKGROUND: The repair of critical bone defects has always been a key problem for clinical surgeons, and bone tissue engineering research provides a new way to solve this problem. How to accelerate the vascularization of tissue-engineered bone and promote the osteogenic differentiation of seed cells is a key problem in the research of bone tissue engineering.  
    OBJECTIVE: To investigate the ability of tissue-engineered bone constructed by co culture system of vascular endothelial cells and adipose derived stem cells and partially deproteinized biological bone to repair bone defects.
    METHODS:  Three kinds of tissue-engineered bone were constructed in vitro: partially deproteinized biological bone + vascular endothelial cells, partially deproteinized biological bone + adipose derived stem cells, partially deproteinized biological bone + adipose derived stem cells + vascular endothelial cells (the ratio of vascular endothelial cells and adipose derived stem cells = 1 : 1), and partially deproteinized biological bone alone was used as control group. Totally 60 18-week-old SD rats were randomly divided into five groups with 12 rats in each group. Four kinds of scaffold materials were implanted into the corresponding mandibular bone defects of SD rats respectively. Only bone defects were made in the blank control group without repair. At 2, 4, 8, and 12 weeks after operation, the animals were killed for gross observation, X-ray examination, hematoxylin-eosin staining, and Masson staining for histological observation. Masson staining sections were taken for quantitative detection of bone collagen.  
    RESULTS AND CONCLUSION: (1) Gross observation showed that the degradation of bone scaffold in the partially deproteinized biological bone + adipose derived stem cells + vascular endothelial cells group was the fastest, and the ability of repairing bone defect was stronger than that in the other groups. Bone defect in the blank control group was not repaired. (2) X-ray examination showed that the partially deproteinized biological bone + adipose derived stem cells + vascular endothelial cells group had bony union at 8 weeks; bone suture had disappeared; bone density increased significantly at 12 weeks; and bone morphology had basically returned to normal. In the other groups, the general shape of the material still existed at 12 weeks, while in the blank control group, the bone defect was not repaired. (3) Histological observation showed that there was no significant difference between partially deproteinized biological bone + adipose derived stem cells group and simple partially deproteinized biological bone group (P=0.607 > 0.05). However, there was significant difference between partially deproteinized biological bone + vascular endothelial cells group and partially deproteinized biological bone + adipose derived stem cells group (P=0.011 < 0.05). There were significant differences between the other groups (P < 0.01). (4) It is concluded that the ability to repair bone defect is the strongest in tissue engineered bone constructed by co-cultured cells, and the influence of vascular endothelial cells is greater than that of adipose derived stem cells.
    Figures and Tables | References | Related Articles | Metrics
    Hypoxic precondition rescues osteogenic potential of bone marrow mesenchymal stem cells derived from ovariectomized rats
    Huang Xiaoxiong, Chen Weikai, Liu Tao, Yang Huilin, He Fan
    2022, 26 (13):  2034-2039.  doi: 10.12307/2022.329
    Abstract ( 446 )   PDF (2056KB) ( 50 )   Save
    BACKGROUND: Hypoxia is one of the main driving forces regulating the angiogenesis-osteogenesis differentiation process. Hypoxia treatment of cells before differentiation is considered to maintain the stemness and enhance the osteogenic potential of stem cells. However, it is not clear whether hypoxic precondition could improve the osteogenic potential of bone marrow mesenchymal stem cells derived from osteoporosis rat.
    OBJECTIVE: To investigate the effects of hypoxic precondition on the osteogenic potential of bone marrow mesenchymal stem cells derived from osteoporosis rat and the role of hypoxia inducible factor-1α. 
    METHODS: Ovariectomized SD rat models were established. Bone marrow mesenchymal stem cells were isolated from femurs of female rats in ovariectomized group and sham operation group. The bone marrow mesenchymal stem cells were divided into three groups. In the normal group, the bone marrow mesenchymal stem cells extracted from the sham rats were cultured in the incubator with normal oxygen concentration (21% O2). In the osteoporosis group, the bone marrow mesenchymal stem cells extracted from the ovariectomized rats were cultured in the incubator with normal oxygen concentration (21% O2). In the hypoxia group, the bone marrow mesenchymal stem cells extracted from the ovariectomized rats were cultured in the hypoxic incubator with hypoxic oxygen concentration (5% O2). CCK-8 assay was used to assess the proliferation capacity of bone marrow mesenchymal stem cells by measuring absorbance values at 1, 3, 5, and 7 days. After 72 hours of incubation in hypoxic environment, cells were moved to normal incubator for osteogenic differentiation with other two groups for 14 days. Alizarin red staining and qRT-PCR were utilized to detect osteogenic related gene expression levels. Finally, the bone marrow mesenchymal stem cells of the osteoporosis group were transfected with small interfering RNA to silence the expression of hypoxia inducible factor-1α, cultured in a hypoxic environment for 72 hours, and transferred to a normal incubator for osteogenic differentiation for 14 days. The changes in osteogenic capacity were observed after silencing hypoxia inducible factor-1α. After the silence of HIF-1α, the expressions of HIF-1α and osteogenic markers were furthered detected.  
    RESULTS AND CONCLUSION: (1) The proliferation ability of bone marrow mesenchymal stem cells in ovariectomized rats decreased, and the osteogenic differentiation ability was impaired. (2) Hypoxia successfully accelerated the proliferation of bone marrow mesenchymal stem cells, promoted the deposition of matrix mineralization and the expression of osteogenic related genes. (3) Positive effects of hypoxic precondition on osteogenic potential after the silence of hypoxia inducible factor-1α were eliminated. (4) Results suggested that hypoxic precondition could improve the proliferation and osteogenic potential of bone marrow mesenchymal stem cells of ovariectomized rats and hypoxia inducible factor-1α activated by hypoxia may play an important effect on osteogenic differentiation.
    Figures and Tables | References | Related Articles | Metrics
    Biocompatibility of plant-derived nerve conduits to nasal ectomesenchymal stem cells
    Zheng Youfei, Shi Wentao, Liu Xiaogu, Zhuang Qin, Lü Demin, Zhang Jiayin, Yuan Yiwen, Zhang Zhijian, Xu Xiaofeng
    2022, 26 (13):  2040-2044.  doi: 10.12307/2022.330
    Abstract ( 394 )   PDF (2015KB) ( 64 )   Save
    BACKGROUND: There are many reports on the repair of peripheral nerve injury by nerve conduit bridging nerve gap instead of autogenous nerve graft. The nasal ectomesenchymal stem cell is an important seed cell for the transplantation of peripheral nerve injury.
    OBJECTIVE: To investigate the biocompatibility of nasal ectomesenchymal stem cells and plant-derived neural conduits and the spontaneous differentiation and growth of nasal ectomesenchymal stem cells on the surface of the conduit.
    METHODS: Tube culms with an inner diameter of 0.2 cm were selected in nature. After physical and chemical removal of pulp, their fibrous tubular shape was retained. The extracellular matrix protein laminin was modified by genipin. Nasal ectomesenchymal stem cells were isolated and cultured in vitro, and divided into three groups: the blank group (blank culture plate), the unmodified group (unmodified conduit) and the modified group (modified conduit). MTT assay was performed at 1, 3, 5, 7, and 14 days to evaluate cell viability. Biocompatibility was assessed in vitro. The effect of the conduit on the spontaneous differentiation of nasal mucosa-derived ectodermal mesenchymal stem cell was observed by immunoblotting and immunofluorescence two weeks after cell implantation and culture. 
    RESULTS AND CONCLUSION: (1) Nasal ectomesenchymal stem cells grow well and were oriented on the surface of plant duct fibers, and plant conduits were biocompatible with nasal ectomesenchymal stem cells. (2) The expression levels of MBP and S100 in nasal ectomesenchymal stem cells implanted on the surface of the catheter were higher than those in the blank and unmodified groups. (3) It is concluded that the differentiation of nasal ectomesenchymal stem cells into Schwann cells can be promoted by laminin-modified plant-derived nerve conduits, which may provide a new theoretical basis for the transplantation and repair of peripheral nerve cells loaded with natural plant-derived nerve conduits.
    Figures and Tables | References | Related Articles | Metrics
    Effect of brain-derived neurotrophic factor modified human amniotic mesenchymal stem cell transplantation on cognitive function in Alzheimer’s disease rats
    Wang Yuxiang, Cui Chuanju, Li Yanling, Li Aifan
    2022, 26 (13):  2045-2049.  doi: 10.12307/2022.331
    Abstract ( 437 )   PDF (1598KB) ( 41 )   Save
    BACKGROUND: Studies have found that human mesenchymal stem cells modified by brain-derived neurotrophic factor (BDNF) can be used to treat spinal cord injury and traumatic brain injury, but whether there is a curative effect on Alzheimer’s disease is rare in the past reports.
    OBJECTIVE: To observe the effects of BDNF modified human amniotic mesenchymal stem cells (hAMSCs) on learning and memory ability and expression of choline acetyltransferase in hippocampus and nerve growth factor in basal forebrain of rats with Alzheimer’s disease. 
    METHODS: Forty healthy male adult SD rats were randomly divided into control group, model group, hAMSCs group and BDNF-hAMSCs group with 10 rats in each group. Bilateral hippocampal injection of β-amyloid 25-35 was used to construct an Alzheimer’s disease model. On day 14, 10 μL of hAMSCs or 10 μL of BDNF were injected into the posterior ventricle to transfect hAMSCs. At 2 weeks after transplantation, learning and memory abilities of rats were evaluated by Morris water maze test. Choline acetyltransferase expression in hippocampus was detected by immunohistochemistry. Nerve growth factor expression in the basal forebrain was detected by RT-PCR.   
    RESULTS AND CONCLUSION: (1) At 3, 4, and 5 days of Morris water maze test, the escape latencies of the hAMSCs group and the BDNF-hAMSCs group were lower than that in the model group (P < 0.05). At 4 and 5 days, the escape latency of the BDNF-hAMSCs group was lower than that of the hAMSCs group (P < 0.05). (2) The number of choline acetyltransferase positive neurons and nerve growth factor expression in the basal forebrain in hippocampus of model group were significantly lower than those of control group (P < 0.05). The number of choline acetyltransferase positive neurons in the hippocampus and nerve growth factor expression in the basal forebrain of the hAMSCs group and the BDNF-hAMSCs group were higher than those of the model group (P < 0.05), and the number of choline acetyltransferase positive neurons and nerve growth factor expression in the BDNF-hAMSCs group were higher than those in the hAMSCs group (P < 0.05). (3) Results suggest that modification of hAMSCs with BDNF can further improve the efficacy of stem cells in the treatment of Alzheimer’s disease, and can significantly increase the expression levels of choline acetyltransferase in the hippocampus and nerve growth factor in the basal forebrain. 
    Figures and Tables | References | Related Articles | Metrics
    Basic fibroblast growth factor promotes the proliferation of stem cells from the apical papilla through activation of Wnt/beta-Catenin signaling pathway
    Fu Yi, Zhang Yu, He Mei, Che Yanlin, Liang Jing, Wu Jiayuan
    2022, 26 (13):  2050-2055.  doi: 10.12307/2022.332
    Abstract ( 358 )   PDF (1845KB) ( 181 )   Save
    BACKGROUND: When basic fibroblast factors act on fibroblasts, they can induce their proliferation by activating Wnt signaling. However, in the study of its effect on apical dental papilla stem cells, whether it can activate the Wnt/β-Catenin signaling pathway and the effect of activating this pathway on the biological activities of apical dental papilla stem cells remains unclear. 
    OBJECTIVE: To investigate the regulatory role of basic fibroblast growth factor on the proliferation of stem cells from apical papilla. 
    METHODS: Human stem cells from apical papilla were cloned and cultured through enzymatic digestion and limiting dilution assay, and then treated with 15 μg/L basic fibroblast growth factor for 2 days. RT-PCR and western blot assay were used to detect the expression of β-Catenin, TCF1, TCF3, and LEF1 mRNAs and proteins. The effect of basic fibroblast growth factor on the proliferation of stem cells from apical papilla was further studied in the case of Wnt/β-Catenin signaling pathway inhibition. The basic fibroblast growth factor (15 μg/L) + Dkk-1 group, basic fibroblast growth factor (15 μg/L) group, and negative control group were set. The proliferation of stem cells from apical papilla in each group was compared by MTT assay and EdU assay. 
    RESULTS AND CONCLUSION: (1) The expression levels of β-Catenin, TCF1, TCF3, and LEF1 mRNAs and proteins were upregulated by 15 μg/L basic fibroblast growth factor on stem cells from apical papilla (P < 0.05). (2) The stem cells from apical papilla of the basic fibroblast growth factor (15 μg/L) group showed stronger proliferation activity than that in the negative control group and basic fibroblast growth factor (15 μg/L) + Dkk-1 group (P < 0.05). (3) Results suggest that basic fibroblast growth factor can promote the expression of key molecules β-Catenin in Wnt/β-Catenin signaling pathway and downstream molecules TCF1, TCF3, and LEF1. Wnt/β-Catenin signaling pathway participates in the regulation of basic fibroblast growth factor on the proliferation of stem cells from apical papilla. 
    Figures and Tables | References | Related Articles | Metrics
    Isolation and identification of human urine-derived stem cell-derived exosomes
    Wang Shuai, Li Chaoran, Zhang Xiru, Huang Guilin
    2022, 26 (13):  2056-2061.  doi: 10.12307/2022.333
    Abstract ( 475 )   PDF (4208KB) ( 54 )   Save
    BACKGROUND: Recent studies have found that the tissue repair and regeneration function of stem cells are largely realized by paracrine function. Exosomes, as one of important paracrine factors, have been proven to play an important role in the repair and regeneration of heart, nerve, bone and retina injury. Researchers are looking for a better source of stem cells-derived exosomes.
    OBJECTIVE: To isolate and identify exosomes secreted by human urine-derived stem cells. 
    METHODS: Human urine-derived stem cells were isolated from urine of healthy male adults and then cultured and passaged. The surface markers were identified by flow cytometry. Human urine-derived stem cells were induced to differentiate into osteoblasts and adipocytes, and identified by alizarin red, Von Kossa and oil red O staining, respectively. Modified ultra-high speed centrifugation was used to isolate exosomes secreted by human urine-derived stem cells from human urine-derived stem cells conditioned medium. Transmission electron microscopy was used to analyze their morphology. Nanoparticle Tracking Analysis was used to analyze the size and concentration. Western blot assay was used to detect the expression of specific protein CD9, CD63 and HSP70. 
    RESULTS AND CONCLUSION: (1) Adherent cell growth was identified in human urine-derived stem cells after 3-5 days of culturing. They resembled “slabstone” in the primary passage, and then resembled “rice” in the first and second passages, and in the third passage, they gradually turned into a “spindle-like shape” or “shuttle-like shape”. Flow cytometry results showed the positive expression of human urine-derived stem cells with mesenchymal stem cell specific surface markers (CD44, CD73, CD90 and CD105). After osteogenic and adipogenic induction in vitro, human urine-derived stem cells successfully differentiated into osteoblasts and adipocytes. (2) After low speed, high speed, ultra-high speed centrifugation, exosomes secreted by human urine-derived stem cells were extracted from conditioned medium of human urine-derived stem cells. Observation by transmission electron microscope showed round or oval membranous vesicles, resembling “saucer”, mainly concentrated with the size of 64-141 nm. Western blot assay showed the protein expression of CD9, CD63 and HSP70 in the exosomes secreted by human urine-derived stem cells. (3) This study confirmed the feasibility of the improved ultra-high speed centrifugation method to extract the exosomes secreted by human urine-derived stem cells.
    Figures and Tables | References | Related Articles | Metrics
    Effect and mechanism of astrocytes in spinal cord injury
    Li Shuai, Fan Yiming, Liu Fangyu, Zhang Hongyu, Wang Yansong
    2022, 26 (13):  2062-2068.  doi: 10.12307/2022.334
    Abstract ( 580 )   PDF (1387KB) ( 55 )   Save
    BACKGROUND: Clinical manifestations of spinal cord injury are related to the severity and location of injury. Although the research on spinal cord injury has lasted for many years, there is still no effective treatment to restore the function of injured spinal cord. 
    OBJECTIVE: To review the characteristics of astrocytes, the activation of reactive astrocytes in recent years and the related therapeutic strategies. 
    METHODS: In PubMed database, the key words of “spinal cord injury, astrocyte” were searched. The key words of “spinal cord injury, astrocyte” were searched in Wanfang and CNKI. The retrieval time limit was from January 2010 to October 2020. According to the inclusion and exclusion criteria, articles unrelated to the research purpose, long-standing and repetitive articles were excluded, and 61 articles meeting the criteria were included for review.  
    RESULTS AND CONCLUSION: The physiological functions of astrocytes are diverse and are very important for maintaining the stability of the central nervous system. Astrocytes can also be activated into reactive astrocytes after spinal cord injury, which will have beneficial or adverse effects on the nervous system. Treatment of spinal cord injury with astrocytes can effectively improve neurological function, reduce inflammatory reaction after spinal cord injury, and promote axon growth and remyelination. The activation types and mechanisms of reactive astrocytes need to be further explored, and the safety and cost issues of related treatment strategies need to be further solved. Therefore, it is necessary to explore the mechanism of astrocytes in spinal cord injury.
    Figures and Tables | References | Related Articles | Metrics
    Expression and function of colony-stimulating factor 1 in differentiation of neural stem cells induced by activated astrocyte conditioned medium
    Shan Wen, Shi Wei
    2022, 26 (13):  2069-2074.  doi: 10.12307/2022.335
    Abstract ( 415 )   PDF (2459KB) ( 40 )   Save
    BACKGROUND: The excessive proliferation of reactive astrocytes after traumatic brain injury may have an impact on the differentiation of neural stem cells into neurons. Therefore, studying the regulation of reactive astrocytes on neural stem cell differentiation after traumatic brain injury and its regulation mechanism may have great clinical application prospect for promoting the recovery of neural function. 
    OBJECTIVE: To investigate the effect of reactive astrocytes on the differentiation of neural stem cells into neurons.
    METHODS: Astrocytes of SD rats were cultured in vitro and divided into control group and lipopolysaccharide stimulation group. After 3 days of intervention, the expression of colony-stimulating factor 1 in astrocytes was detected by PCR, ELISA and western blot assay. Primary neural stem cells of SD rats were cultured in vitro, and astrocyte conditioned medium was added to the neuron induction medium for 3 days. Immunofluorescence and flow cytometry were used to detect the expression of β-tubulin III and glial fibrillary acidic protein. Primary neural stem cells were cultured in vitro, and the recombinant protein of colony-stimulating factor-1 was added to the neuron induction medium for 3 days. The effect of colony-stimulating factor-1 on the differentiation of neural stem cells into neurons was detected by flow cytometry and immunofluorescence.
    RESULTS AND CONCLUSION: (1) The expression of colony-stimulating factor-1 in astrocytes stimulated by lipopolysaccharide and in conditioned medium was very low. (2) The coculture of neural stem cells and astrocyte conditioned medium stimulated by lipopolysaccharide inhibited the differentiation of neural stem cells into neurons. (3) Neural stem cells promoted the differentiation of neural stem cells into neurons by adding colony stimulating factor 1 recombinant protein. (4) The results showed that colony-stimulating factor 1 secretion of astrocytes was down-regulated after stimulation with lipopolysaccharide, and inhibited the differentiation of neural stem cells into neurons. The overexpression of colony-stimulating factor 1 can promote the differentiation of neural stem cells into neurons, which can repair brain injury in rats. 
    Figures and Tables | References | Related Articles | Metrics
    Effects of various methods on improving bone marrow mesenchymal stem cell transplantation for spinal cord injury
    Sun Jianwei, Yang Xinming, An Xiaogang
    2022, 26 (13):  2075-2080.  doi: 10.12307/2022.336
    Abstract ( 496 )   PDF (1194KB) ( 218 )   Save
    BACKGROUND: Bone marrow mesenchymal stem cells are adult pluripotent stem cells with strong proliferation and multi-differentiation potential without ethics and rejection. They have been proven effective in a large number of spinal cord injury-related experiments and become the most promising seed cells for treatment of spinal cord injury.
    OBJECTIVE: To summarize the latest research progress of various treatment methods to promote bone marrow mesenchymal stem cell transplantation for spinal cord injury.
    METHODS: Related articles were retrieved in CNKI, Wanfang and PubMed databases from January 1999 to October 2020, with the search terms of “bone marrow mesenchymal stem cells, cell transplantation, spinal cord injury” in Chinese and English. Basic and clinical studies of bone marrow mesenchymal stem cell transplantation for spinal cord injury were screened, and repetitive studies were excluded. A total of 66 articles were included in the study. 
    RESULTS AND CONCLUSION: (1) Bone marrow mesenchymal stem cell transplantation combined with other treatments can significantly improve the therapeutic effect of spinal cord injury, among which the combination of biological tissue engineering or related drugs is an important research direction in the treatment of spinal cord injury in the future. (2) Bone marrow mesenchymal stem cell transplantation has great potential in the clinical treatment of spinal cord injury.
    Figures and Tables | References | Related Articles | Metrics
    Effect and mechanism of traditional Chinese medicine regulating mesenchymal stem cell-derived exocrine for ischemic stroke
    Chen Na, Fan Feiyan, Li Shuangli, Zhang Yunke
    2022, 26 (13):  2081-2086.  doi: 10.12307/2022.337
    Abstract ( 466 )   PDF (1164KB) ( 103 )   Save
    BACKGROUND: Exosome is a membranous vesicle structure, which can be secreted by many types of cells and widely exists in blood, urine, cerebrospinal fluid, breast milk and other body fluids. It has the potential to mediate cell-to-cell communication and activate a variety of signal pathways. Studies have shown that mesenchymal stem cell-derived exocrine bodies can not only directly affect the function of brain parenchyma cells, but also have indirect neural repair effect, as a drug loading system can improve the therapeutic effect of traditional Chinese medicine.
    OBJECTIVE: To review the research progress on the mechanism of mesenchymal stem cell-derived exocrine bodies regulated by traditional Chinese medicine in the treatment of ischemic stroke.
    METHODS: The articles of Wanfang, CNKI, PubMed, Web of Science and other databases about mesenchymal stem cell-derived exocrine bodies regulated by traditional Chinese medicine in the treatment of ischemic stroke from 2009 to 2020 were searched, with “mesenchymal stem cells, exocrine, traditional Chinese medicine, ischemic stroke” as the key words in Chinese and English. The outdated and repetitive viewpoints were excluded, and the retrieved articles were analyzed and sorted out, and a total of 66 articles were included for analysis.
    RESULTS AND CONCLUSION: (1) The biological characteristics of exocrine derived from mesenchymal stem cells were combed. (2) Summarizing the mechanism of mesenchymal stem cell-derived exocrine in the treatment of ischemic stroke, including affecting blood-brain barrier permeability, angiogenesis, neurodifferentiation, nerve repair and immune inflammation. (3) Through the existing research, this paper summarizes the role of traditional Chinese medicine in regulating mesenchymal stem cell-derived exocrine in the treatment of ischemic stroke, including neuroprotection, angiogenesis, regulation of blood-brain barrier and so on. It may provide relevant reference for the clinical application of traditional Chinese medicine to regulate mesenchymal stem cell-derived exocrine in the treatment of ischemic stroke in the future. 
    Figures and Tables | References | Related Articles | Metrics
    Action mechanism of traditional Chinese medicine on regulating ischemia-hypoxia microenvironment and delaying stem cell senescence based on ciRs-7/miR-7 signaling pathway
    Wang Shiqi, Hui Xiaoshan, An Lanhua, Yuan Shuzhang, Zhang Jinsheng
    2022, 26 (13):  2087-2092.  doi: 10.12307/2022.338
    Abstract ( 452 )   PDF (1383KB) ( 145 )   Save
    BACKGROUND: Stem cell senescence is a part of the body’s aging. Regulating the ischemia-hypoxia microenvironment through extracellular signaling pathways may be an important method to delay stem cell aging. 
    OBJECTIVE: To explore the mechanisms and methods of delaying stem cell senescence based on the relationship between extracellular signaling pathway and ischemia-hypoxia microenvironment in recent years.
    METHODS: Using the keywords of “ciRs-7/miR-7, stem cell, ischemia-hypoxia microenvironment, aging” in Chinese and English, we searched Chinese Journal Full-Text Database, PubMed and Wanfang Database for articles about the effects of ciRs-7/miR-7 signaling pathway and ischemia-hypoxia microenvironment on stem cell senescence from 1978 to 2021. Finally, 56 articles were reviewed.  
    RESULTS AND CONCLUSION: The level of proliferation, differentiation and autophagy of stem cells decreased and the senescence process of stem cells accelerated under the ischemia-hypoxia microenvironment. Stem cell aging is an important cause of body aging. Delaying stem cell aging by regulating extracellular signaling pathway ciRs-7/miR-7 may become a new method of anti-aging.
    Figures and Tables | References | Related Articles | Metrics
    Function and hot spot of adipose-derived stem cell exosomes in tissue regeneration and repair
    Li Jianyi, Liu Zhiyuan, Deng Chengliang
    2022, 26 (13):  2093-2098.  doi: 10.12307/2022.339
    Abstract ( 592 )   PDF (1123KB) ( 40 )   Save
    BACKGROUND: Adipose-derived stem cells have become one of the popular seed cells in regenerative medicine due to abundant content and easy harvest. Adipose-derived stem cell exosomes are served as a bridge and link among adipose-derived stem cells and other cells and have the effects on regulating immune and inflammatory responses, promoting self-repair of damaged cells, and are considered as an alternative treatment for adipose-derived stem cells. 
    OBJECTIVE: To review research progress and challenges in the adipose-derived stem cell exosomes regulating tissue regeneration. 
    METHODS:  CNKI, Wanfang database and PubMed, and Web of Science database were searched for related articles with the search terms of “adipose-derived stem cells; adipose stem cells; exosomes” in English and Chinese. After preliminary screening of articles based on inclusion and exclusion criteria, 70 articles with high relevance and reference value were retained for review.
    RESULTS AND CONCLUSION: Adipose-derived stem cell exosomes have shown the therapeutic potential in various diseases, such as skin wounds, neurodegenerative diseases, tumors, bone regeneration, kidney diseases, cardiovascular diseases, immune diseases, and fibrotic disease.
    Figures and Tables | References | Related Articles | Metrics
    Potential new target effects between exosomes derived from mesenchymal stem cells and various hematological tumors
    Li Lichun, Li Xiaofeng, Li Jianping
    2022, 26 (13):  2099-2105.  doi: 10.12307/2022.340
    Abstract ( 411 )   PDF (1269KB) ( 40 )   Save
    BACKGROUND: Mesenchymal stem cells are pluripotent stem cells that exist in various tissues. The exosomes are communication carriers between cells, which can deliver biologically active molecules, such as lipids, nucleic acids and proteins between cells. Exosomes derived from mesenchymal stem cells are the main component of the tumor microenvironment and play an important role in the development, angiogenesis, and metastasis of tumors.
    OBJECTIVE: To review the new developments in the diagnosis, treatment and prognosis of exosomes derived from mesenchymal stem cells in hematological tumors, and explain the potential new target effects between it and various hematological malignancies. 
    METHODS: A computer search was performed for articles related to exosomes derived from mesenchymal stem cells in PubMed, CNKI, and Wanfang databases from January 1900 to April 2021. Chinese and English search terms were “mesenchyma stem cell, exosomes, hematological tumor”. A total of 440 articles were retrieved, and 59 articles that met the subject criteria were finally included. 
    RESULTS AND CONCLUSION: (1) With the introduction of the concept of precision medicine, exosomes derived from mesenchymal stem cells are considered to be an important way for cells to communicate with each other. (2) As a biological tumor of hematology and important mediator of markers and cell-to-cell transmission, mesenchymal stem cell-derived exosomes have played an important role in abnormal coagulation in hematological malignancies, promoting blood vessel formation, inhibiting bone marrow hematopoiesis, changing the bone marrow hematopoietic microenvironment, affecting the immune system, reducing tumor cell apoptosis and drug resistance mechanisms and other aspects. (3) Exosomes derived from mesenchymal stem cells still face many challenges in the process of clinical application. Continuous improvement and standardization of exosomes separation and purification methods are required to ensure the safety of clinical applications of exosomes and enhance the comparability and reproducibility of clinical applications. (4) The pharmacokinetics, biogenesis, and biodistribution mechanism of mesenchymal stem cell-derived exosomes in the treatment of clinical hematological tumors are still in the initial stage of clinical research. How various biomolecules transported by exosomes can regulate recipient cells and change the state and fate of cells in the body is still unknown. (5) In-depth research requires us to make a new discovery between mesenchymal stem cell-derived exosomes and various hematological malignancies in order to provide a better experimental basis for the diagnosis, treatment and prognosis of human hematological tumor diseases.
    Figures and Tables | References | Related Articles | Metrics
    Application of single-cell RNA sequencing in diagnosis and treatment of corneal and retinal diseases
    Huang Chang, Ying Peixi, Yi Guoguo, Fu Sheng, Wang Yan, Guo Xi, Zhang Yuxi, Fu Min
    2022, 26 (13):  2106-2113.  doi: 10.12307/2022.341
    Abstract ( 580 )   PDF (2191KB) ( 74 )   Save
    BACKGROUND: Single-cell RNA sequencing, as a new generation of mRNA sequencing method, has gradually matured and been applied in ophthalmic research after more than ten years of development. 
    OBJECTIVE: To review the development of single cell RNA sequencing and its application and progress in ophthalmology.
    METHODS:  The relevant articles in PubMed, Sciencedirect, and Web of Science databases were searched by computer. English key words were “single-cell RNA-seq, retina, cornea, gene marker”. The retrieval time was from January 1, 2006 to January 31, 2021. The articles were screened initially through reading and analysis to exclude duplicates and low-relevance articles. Finally, 80 articles were included for results analysis. 
    RESULTS AND CONCLUSION:  (1) Single cell RNA sequencing is on the single cell level, of genome, transcriptome, and epigenome high-throughput sequencing analysis technology. Compared with the conventional sequencing method, it can be further applied to study the differences between the cells, explain cell subtype and specific expression genes, to explore the disease occurrence, development and resistance mechanism, and provide new targets for the immune therapy. (2) Currently, there are many branches of single-cell RNA sequencing, such as STRT-seq, Smart-seq, CEL-seq, MARS-seq, Cyto-seq, Drop-seq, inDrop-seq, and Seq-Well. These technologies have their own advantages and application fields. For example, STRT-seq is only at the 5’ end and does not have chain specificity, whereas Samrt-seq transcriptional coverage is full-length. (3) In the field of ophthalmology, single-cell RNA sequencing is mainly used in the study of cornea and retina. There are new scientific discoveries in the identification of new subtypes of eye cells and the diagnosis of ophthalmic diseases and potential immunotherapy. A few are used in the study of lens diseases and uveal melanoma. (4) The research of single-cell RNA sequencing technology in the field of cornea is mainly about keratoconus disease and corneal epithelial cell gene expression. Notch1 and PLLP genes were proven to be related to the pathogenesis of keratoconus. The expression of Krt15, Fzd7, and Krt17 genes increased in corneal basal cells, while Sox9, Actn1, and Anxa3 were mainly expressed in basal epithelial progenitor cells. In addition, retinal tissue is a kind of tissue that is easy to obtain and observe. In recent years, single-cell RNA sequencing technology has been applied to study the gene expression of normal retinal tissue cell subtypes and retinal-related diseases, such as age-related macular degeneration and retinoblastoma. (5) Single-cell RNA sequencing technology can accurately reflect the gene expression of a single cell. In recent years, it has been used to study the gene expression, cell subtypes and signaling pathways of cornea and retina, and will play an important role in the treatment of ophthalmic diseases in the future.
    Figures and Tables | References | Related Articles | Metrics
    Role and mechanism of cell therapy in repair of peripheral nerve injury
    Gong Chao, Zhang Yuqiang, Wang Wei
    2022, 26 (13):  2114-2119.  doi: 10.12307/2022.342
    Abstract ( 405 )   PDF (1185KB) ( 128 )   Save
    BACKGROUND: Cell therapy is a promising branch of medical tissue engineering and regenerative medicine, and which is a good strategy for the repair of peripheral nerve injury.
    OBJECTIVE: To review the common repair methods of peripheral nerve injury, several cells commonly used for peripheral nerve injury repair and the mechanism of cell therapy to promote peripheral nerve injury repair.
    METHODS: The key words were “cell therapy, stem cell therapy, peripheral nerve injury, repair” in English and Chinese. Wanfang, CNKI and PubMed databases were retrieved for the articles concerning the cell therapy in the repair of peripheral nerve injury published from 2010 to 2020. After excluding repetitive, old and irrelevant articles, 45 eligible articles were further analyzed. 
    RESULTS AND CONCLUSION: (1) After summarizing the common repair methods of peripheral nerve injury, such as conventional direct suture, nerve graft, and nerve transfer, and the advantages and disadvantages of each method were described. (2) Several kinds of cells commonly used for peripheral nerve injury repair, such as Schwann cells, olfactory ensheathing cells, and embryonic stem cells, were reviewed, and the defects of various cells were pointed out. (3) The mechanism of cell therapy to promote peripheral nerve injury repair was summarized, which was mainly manifested in the application of Schwann cells or Schwann cells-like cells, secretion of neurotrophic factors, extracellular matrix molecules and cell adhesion molecule, and promotion of myelin formation.
    Figures and Tables | References | Related Articles | Metrics
    Progress of macrophage polarization in immunology of bone tissue engineering
    Zhao Yuexin, Chen Bin
    2022, 26 (13):  2120-2126.  doi: 10.12307/2022.343
    Abstract ( 497 )   PDF (1163KB) ( 151 )   Save
    BACKGROUND: Bone tissue engineering is an effective bone defect repair program. Macrophages play an extremely important role in the immune response after implantation of tissue engineering materials. Interfering with its different polarization states has become a key means to regulate the local immune microenvironment.
    OBJECTIVE: To summarize the important role of macrophages in the immune response after biomaterial implantation and the research progress in promoting osteogenesis by regulating the polarization of macrophages in bone tissue engineering. 
    METHODS: PubMed, Web of Science and CNKI were used to search the related articles published from 2016 to 2020. The retrieval article types were original research works and reviews. The search terms were “macrophage polarization, M2, scaffold, tissue engineering, foreign body response, implant, surface, bone” in English, and “macrophage polarization, M2, tissue engineering, foreign body response, implant, surface, bone” in Chinese. An inductive analysis was conducted in the selected articles on the latest research progress in this field.
    RESULTS AND CONCLUSION: The immune response plays an important role in tissue engineering and the regulation of the immune microenvironment is a key means of promoting osteogenesis in tissue engineered bone. The method of altering the physicochemical properties of the material, such as hydrophobicity, roughness and surface morphology has good stability for a long duration, achieves significant osteogenic improvements. Delivery of drugs, cytokines or bioactive ions has also worked well, but suffers from short release time and susceptibility to denaturation. Another strategy is regulation by engineered cell-macrophage crosstalk, where mesenchymal stem cells are highly immunomodulatory and can achieve immune modulation and bone repair promotion. The new study highlights the important role of exosomes to achieve controllable modulation of macrophage polarization and immune environment.
    Figures and Tables | References | Related Articles | Metrics
    Regulatory effects of hypoxic culture on physiological activities of mesenchymal stem cells
    Liu Ziwen, Wang Wenbo
    2022, 26 (13):  2127-2132.  doi: 10.12307/2022.344
    Abstract ( 408 )   PDF (1468KB) ( 61 )   Save
    BACKGROUND: Mesenchymal stem cells are multipotent stem cells owing the ability of self-renewal and multiple differentiation potential, which promise mesenchymal stem cells to differentiate into several cell types, including osteoblasts, adipocytes, chondrocytes, myocytes and neurons and so on. Mesenchymal stem cells can secrete factors associated with cell proliferation and survival, immunomodulation, and recruitment. These potentials and characteristics make mesenchymal stem cells an ideal cell source for cell-based treatment of tissues repair in regenerative medicine. Since the oxygen constitution only at range of 3%-8% in healthy bone marrow which is much lower than the normal oxygen concentration of 21%, and this concentration will become lower in the injured tissue microenvironment. Thus, the fate of mesenchymal stem cells in hypoxic environment attracts lots of attention. 
    OBJECTIVE: To explicate the roles of hypoxic condition in mesenchymal stem cells properties and the therapeutic effect of mesenchymal stem cells transplantation. 
    METHODS: The articles about effect of hypoxia on mesenchymal stem cell were searched in CNKI, Wanfang, and PubMed from 2006 to 2020. The search key words were “mesenchymal stem cells, hypoxia culture, stem cell therapy” in Chinese, and “mesenchymal stem cells, hypoxia, regenerative therapy” in English. The collected literature was sorted out to eliminate obsolete concepts and repeated views, and 73 articles were finally selected for analysis. 
    RESULTS AND CONCLUSION: Hypoxic culture could promote cell proliferation, migration ability of mesenchymal stem cells and regulate cell differentiation. In clinical treatment, hypoxic preconditioning could regulate the differentiation ability of mesenchymal stem cells, improve cell survival rate, accelerate tissue healing, and improve the therapeutic effect. Hypoxic culture on the regulation of mesenchymal stem cells provides a new idea for the clinical treatment of osteoporosis and transplantation regenerative therapy.
    Figures and Tables | References | Related Articles | Metrics